Modern methods of fertility preservation in female patients with reproductive system cancers

1. Vitale S.G., La Rosa V.L., Rapisarda A.M., Laganà A.S. Psychology of infertility and assisted reproductive treatment: the Italian situation. J. Psychosom. Obstet. Gynaecol. 2017; 38(1): 1-3. https://dx.doi.org/10.1080/0167482X.2016.1244184.
2. Angarita A.M., Johnson C.A., Fader A.N., Christianson M.S. Fertility preservation: a key survivorship issue for young women withc. Front. Oncol. 2016; 6: 102. https://dx.doi.org/10.3389/fonc.2016.00102.
3. Letourneau J.M., Ebbel E.E., Katz P.P., Katz A., Ai W.Z., Chien A.J. et al. Pre-treatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer. 2012; 118(6): 1710-7. https://dx.doi.org/10.1002/cncr.26459.
4. Loren A.W., Mangu P.B., Beck L.N., Brennan L., Magdalinski A.J., Partridge A.H. et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. 2013; 31(19): 2500-10. https://dx.doi.org/10.1200/JCO.2013.49.2678.
5. Forman E.J., Anders C.K., Behera M.A. Pilot survey of oncologists regarding treatment-related infertility and fertility preservation in female cancer patients. J. Reprod. Med. 2009; 54(4): 203-7.
6. Fisch B., Abir R. Fem013ale fertility preservation: past, present and future. Repro-duction. 2018; 156(1): F11-27. https://dx.doi.org/10.1530/REP-17-0483.
7. Cakmak H., Rosen M. Random-start ovarian stimulation in patients with cancer. Curr. Opin. Obstet. Gynecol. 2015; 27: 215-21. https://dx.doi.org/10.1097/GCO.0000000000000180.
8. Park C.W., Lee S.H., Yang K.M., Lee I.H., Lim K.T., Lee K.H., Kim T.J. Cryo-preservation of in vitro matured oocytes after ex vivo oocyte retrieval from gynecologic cancer patients undergoing radical surgery. Clin. Exp. Reprod. Med. 2016; 43(2): 119-25. https://dx.doi.org/10.5653/cerm.2016.43.2.119.
9. Dinikina Yu., Belogurova M., Zaritskey A., Govorov I., Tsibizova V., Gamzatova Z., Pervunina T., Komlichenko E. Ovarian tissue cryopreservation in prepubertal patients with oncological diseases: multidisciplinary approach and outcomes. J. Matern. Fetal Neonatal Med. 2021; 34(14): 2391-8. https://dx.doi.org/10.1080/14767058.2019.1666364.
10. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015; 65(1): 5-29. https://dx.doi.org/10.3322/caac.21254.
11. Kyono K., Doshida M., Toya M., Sato Y., Akahira J., Sasano H. Potential indica-tions for ovarian autotransplantation based on the analysis of 5,571 autopsy find-ings of females under the age of 40 in Japan. Fertil. Steril. 2010; 93(7): 2429-30. https://dx.doi.org/10.1016/j.fertnstert.2009.08.031.
12. https://www.cancer.gov/types/ovarian
13. American Cancer Society. 2016. Available at: http://www.cancer.org/cancer/ovariancancer/index Accessed 02.04.18.
14. McCorkle R., Pasacreta J., Tang S.T. The silent killer: Psychological issues in ovarian cancer. Holist. Nurs. Pract. 2003; 17(6): 300-8. https://dx.doi.org/10.1097/00004650-200311000-00005.
15. National Cancer Institute. Recurrent or persistent ovarian epithelial cancer treatment. 2014. Available at: http://www.cancer.gov/cancertopics/pdq/treatment/ ovari-anepithelial/HealthProfessional/page6
16. Skirnisdottir I., Garmo H., Wilander E., Holmberg L. Borderline ovarian tumors in Sweden 1960–2005: trends in incidence and age at diagnosis compared to ovarian cancer. Int. J. Cancer. 2008; 123(8): 1897-901. https://dx.doi.org/10.1002/ijc.23724.
17. Gershenson D.M. Fertility-sparing surgery for malignancies in women. J. Natl. Cancer Inst. Monogr. 2005; (34): 43-7. https://dx.doi.org/10.1093/jncimonographs/lgi011.
18. Ditto A., Bogani G., Martinelli F., Raspagliesi F. Fertility-sparing surgery in high-risk ovarian cancer. J. Gynecol. Oncol. 2015; 26(4): 350-1. https://dx.doi.org/10.3802/jgo.2015.26.4.350.
19. Bentivegna E., Maulard A., Miailhe G., Gouy S., Morice P. Gynaecologic cancer surgery and preservation of fertility. J. Visc. Surg. 2018; 155(Suppl. 1): S23-9. https://dx.doi.org/10.1016/j.jviscsurg.2018.03.001.
20. Taylan E., Oktay K. Fertility preservation in gynecologic cancers. Gynecol. Oncol. 2019; 155(3): 522-9. https://dx.doi.org/10.1016/j.ygyno.2019.09.012.
21. Wang T.H., Wang H.S., Soong Y.K. Paclitaxel-induced cell death: where the cell cycle cycle and apoptosis come together. Cancer. 2000; 88(11): 2619-28. https://dx.doi.org/10.1002/1097-0142(20000601)88:11<2619::aid-cncr26>3.0.co;2-j.
22. Arrivé L., Chang Y.C., Hricak H., Brescia R.J., Auffermann W., Quivey J.M. Radiation-induced uterine changes: MR imaging. Radiology. 1989; 170(1, Pt.1): 55-8. https://dx.doi.org/10.1148/radiology.170.1.2909120.
23. Reh A.E., Lu L., Weinerman R., Grifo J., Krey L., Noyes N. Treatment outcomes and quality-of-life assessment in a university-based fertility preservation program: results of a registry of female cancer patients at 2 years. J. Assist. Reprod. Genet. 2011; 28(7): 635-41. https://dx.doi.org/10.1007/s10815-011-9559-z.
24. AIOM: Scientific Documents [Internet]. Milan: Italian Association of Medical Oncology; 2017. Guidelines "Preservation of fertility in cancer patients". 2015. [cited 2016 Dec 1]; [about 2 screens].
25. Gubbala K., Laios A., Gallos I., Pathiraja P., Haldar K., Ind T. Outcomes of ovarian transposition in gynaecological cancers; a systematic review and meta-analysis. J. Ovarian Res. 2014; 7: 69. https://dx.doi.org/10.1186/1757-2215-7-69.
26. Сидоренко Ю.С., Неродо Г.А., Левченко О.Е., Крузе П.А. Сохранение функции яичников в процессе комбинированного лечения рака шейки матки. Опухоли женской репродуктивной системы. 2012; 1: 113-6. [Sidorenko Yu.S., Nerodo G.A., Levchenko O.E., Kruse P.A. Preservation of ovarian function in the course of combined treatment of cervical cancer. Tumors of the female reproductive system. 2012; 1: 113-6. (in Russian)].
27. Steigrad S., Hacker N.F., Kolb B. In vitro fertilization surrogate pregnancy in a patient who underwent radical hysterectomy followed by ovarian transposition, lower abdominal wall radiotherapy, and chemotherapy. Fertil. Steril. 2005; 83(5): 1547-9. https://dx.doi.org/10.1016/j.fertnstert.2005.01.093.
28. Hoekman E.J., Broeders E., Louwe L.A., Nout R.A., Jansen F.W., de Kroon C.D. Ovarian function after ovarian transposition and additional pelvic radiotherapy: a systematic review. Eur. J. Surg. Oncol. 2019; 45(8): 1328-40. https://dx.doi.org/10.1016/j.ejso.2019.02.017.
29. De Vos M., Smitz J., Woodruff T. Fertility preservation in women with cancer. Lancet. 2014; 384(9950): 1302-10. https://dx.doi.org/10.1016/S0140-6736(14)60834-5.
30. Назаренко Т.А., Сухих Г.Т., Мишиева Н.Г. Бесплодие и возраст. М.: МЕДпресс-информ; 2014. 266с. [Nazarenko T.A., Sukhikh G.T., Mishieva N.G. Infertility and age. M.: MEDpress-inform; 2014. 266 p. (in Russian)].
31. Katayama K.P., Stehlik J., Kuwayama M., Kato O., Stehlik E. High survival rate of vitrified human oocytes results in clinical pregnancy. Ferti. Steril. 2003; 80(1): 223-4. https://dx.doi.org/10.1016/s0015-0282(03)00551-x.
32. Fain-Kahn V., Poirot C., Uzan C., Prades M., Gouy S., Genestie C. et al. Feasibility of ovarian cryopreservation in borderline ovarian tumours. Hum. Reprod. 2009; 24(4): 850-5. https://dx.doi.org/10.1093/humrep/den459.
33. Pavone M.E., Confino R., Steinberg M. Female fertility preservation: a clinical perspective. Minerva Ginecol. 2016; 68(4): 458-65.
34. Anderson R.A., Amant F., Braat D., D'Angelo A., Chuva de Sousa Lopes S.M., Demeestere I. et al.; ESHRE Guideline Group on Female Fertility Preservation. ESHRE guideline: female fertility preservation. Hum. Reprod. Open. 2020; 2020(4): hoaa052.
35. Gemmell L.C., Wright J.D., Brady P.C. Triple stimulation (TriStim) before bilateral oophorectomy in a young woman with ovarian cancer: a case report and review of the literature. Fertil. Res. Pract. 2020; 6: 17. https://dx.doi.org/10.1186/s40738-020-00087-y.
36. Filippi F., Martinelli F., Somigliana E., Franchi D., Raspagliesi F., Chiappa V. Oocyte cryopreservation in two women with borderline ovarian tumor recurrence. J. Assist. Reprod. Genet. 2020; 37(5): 1213-6. https://dx.doi.org/10.1007/s10815-020-01733-6.
37. Donnez J., Dolmans M.M. Fertility preservation in women. N. Engl. J. Med. 2017; 377(17): 1657-65. https://dx.doi.org/10.1056/NEJMra1614676.
38. Silber S. Ovarian tissue cryopreservation and transplantation: scientific implications. J. Assist. Reprod. Genet. 2016; 33(12): 1595-603. https://dx.doi.org/10.1007/s10815-016-0814-1.
39. Silber S., Kagawa N., Kuwayama M., Gosden R. Duration of fertility after fresh and frozen ovary transplantation. Fertil. Steril.t 2010; 94(6): 2191-6. https://dx.doi.org/10.1016/j.fertnstert.2009.12.073.
40. Dittrich R., Mueller A., Maltaris T., Hoffmann I., Magener A., Oppelt P.G. et al. Hormonal and histologic findings in human cryopreserved ovarian autografts. Fer-til. Steril. 2009; 91(4, Suppl.):1503-6. https://dx.doi.org/10.1016/j.fertnstert.2008.08.023.
41. Donnez J., Silber S., Andersen C.Y., Demeestere I., Piver P., Meirow D. et al. Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann. Med. 2011; 43(6): 437-50. https://dx.doi.org/10.3109/07853890.2010.546807.
42. Donnez J., Dolmans M.-M. Transplantation of ovarian tissue. Best Pract. Res. Clin. Obstet. Gynaecol. 2014; 28(8): 1188-97.
43. Jensen A.K., Kristensen S.G., Macklon K.T., Jeppesen J.V., Fedder J., Ernst E. et al. Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark. Hum. Reprod. 2015; 30(12): 2838-45. https://dx.doi.org/10.1093/humrep/dev230.
44. Dittrich R., Hackl J., Lotz L., Hoffmann I., Beckmann M.W. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center. Fertil. Steril. 2015; 103(2): 462-8. https://dx.doi.org/10.1016/j.fertnstert.2014.10.045.
45. Kristensen S.G., Giorgione V., Humaidan P., Alsbjerg B., Bjørn A.-M.B., Ernst E., Andersen C.Y. Fertility preservation and refreezing of transplanted ovarian tissue – a potential new way of managing patients with low risk of malignant cell recurrence. Fertil. Steril. 2017; 107(5): 1206-13. https://dx.doi.org/10.1016/j.fertnstert.2017.03.017.
46. Meirow D. Fertility preservation in cancer patients using stored ovarian tissue: clinical aspects. Curr. Opin. Endocrinol. Diabetes Obes. 2008; 15(6): 536-47. https://dx.doi.org/10.1097/MED.0b013e32831a44a8.
47. Kim S., Lee Y., Lee S., Kim T. Ovarian tissue cryopreservation and transplantation in patients with cancer. Obstet. Gynecol. Sci. 2018; 61(4): 431-42. https://dx.doi.org/10.5468/ogs.2018.61.4.431.
48. Fatemi H.M., Kyrou D., Al-Azemi M., Stoop D., De Sutter P., Bourgain C., Devroey P. Ex-Vivo oocyte retrieval for fertility preservation. Fertil. Steril. 2011; 95(5): 1787. e15-7. https://dx.doi.org/10.1016/j.fertnstert.2010.11.023.
49. Trounson A., Wood C., Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil. Steril. 1994; 62(2): 353-62. https://dx.doi.org/10.1016/s0015-0282(16)56891-5.
50. De Vos M., Smitz J., Thompson J.G., Gilchrist R.B. The definition of IVM is clear – variations need defining. Hum. Reprod. 2016; 31(11): 2411-5. https://dx.doi.org/10.1093/humrep/dew208.
51. Revel A. Oocyte collection during cryopreservation of the ovarian cortex. Fertil. Steril. 2003; 79(5): 1237-9. 10.1016/S0015-0282(02)04963-4.
52. Cha K.Y., Koo J.J., Ko J.J., Choi D.H., Han S.Y., Yoon T.K. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil. Steril. 1991; 55(1): 109-13. https://dx.doi.org/10.1016/s0015-0282(16)54068-0.
53. Söderström-Anttila V., Salokorpi T., Pihlaja M., Serenius-Sirve S., Suikkari A.-M. Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum. Reprod. 2006; 21(6): 1508-13. https://dx.doi.org/10.1093/humrep/dei503.
54. Shu-Chi M., Jiann-Loung H., Yu-Hung L., Tseng-Chen S., Ming-I L., Tsu-Fuh Y. Growth and development of children conceived by in vitro maturation of human oocytes. Early Hum. Dev. 2006; 82(10): 677-82. https://dx.doi.org/10.1016/j.earlhumdev.2006.01.012.
55. Prasath E.B., Chan M.L., Wong W.H., Lim C.J., Tharmalingam M.D., Hendricks M., Loh S.F., Chia Y.N. First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient. Hum. Reprod. 2014; 29(2): 276-8. https://dx.doi.org/10.1093/humrep/det420.
56. Segers I., Mateizel I., Van Moer E., Smitz J., Tournaye H., Verheyen G., De Vos M. In vitro maturation (IVM) of oocytes recovered from ovariectomy specimens in the laboratory: a promising “ex vivo” method of oocyte cryopreservation resulting in the first report of an ongoing pregnancy in Europe. J. Assist. Reprod. Genet. 2015; 32(8): 1221-31. https://dx.doi.org/10.1007/s10815-015-0528-9.
57. Uzelac P.S., Delaney A.A., Christensen G.L., Bohler H.C.L., Nakajima S.T. Live birth following in vitro maturation of oocytes retrieved from extracorporeal ovarian tissue aspiration and embryo cryopreservation for 5 years. Fertil. Steril. 2015; 104(5): 1258-60. https://dx.doi.org/10.1016/j.fertnstert.2015.07.1148.
58. Kirillova A., Kovalskaya E., Brovkina O., Ekimov A., Bunyaeva E., Gordiev M., Mishieva N., Nazarenko T., Abubakirov A., Sukikh G. Cryopreservation of euploid blastocysts obtained after fertilization of in vitro matured ovarian tissue oocytes: a case report. J. Assist. Reprod. Genet. 2020; 37(4): 905-11. https://dx.doi.org/10.1007/s10815-020-01729-2.
59. Segers I., Bardhi E., Mateizel I., Van Moer E., Schots R., Verheyen G., Tournaye H., De Vos M. Live births following fertility preservation using in-vitro maturation of ovarian tissue oocytes. Hum. Reprod. 2020; 35(9): 2026-36. https://dx.doi.org/10.1093/humrep/deaa175.
60. Donnez J., Dolmans M.M., Demylle D., Jadoul P., Pirard C., Squifflet J. et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004; 364(9443):1405-10. https://dx.doi.org/10.1016/S0140-6736(04)17222-X.
61. Silber S.J., Lenahan K.M., Levine D.J., Pineda J.A., Gorman K.S., Friez M.J. et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N. Engl. J. Med. 2005; 353(1): 58-63. https://dx.doi.org/10.1056/NEJMoa043157.
62. Meirow D., Levron J., Eldar-Geva T., Hardan I., Fridman E., Zalel Y. et al. Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N. Engl. J. Med. 2005; 353(3): 318-21. https://dx.doi.org/10.1056/NEJMc055237.
63. Demeestere I., Simon P., Emiliani S., Delbaere A., Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist. 2007; 12(12): 1437-42. https://dx.doi.org/10.1634/theoncologist.12-12-1437.
64. Andersen C.Y., Rosendahl M., Byskov A.G., Loft A., Ottosen C., Dueholm M. et al. Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum. Reprod. 2008; 23(10): 2266-72. https://dx.doi.org/10.1093/humrep/den244.
65. Jensen A.K., Macklon K.T., Fedder J., Ernst E., Humaidan P., Andersen C.Y. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen- thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. J. Assist. Reprod. Genet. 2017; 34: 325-36. https://dx.doi.org/10.1007/s10815-016-0843-9.
66. Dolmans M.-M., Jadoul P., Gilliaux S., Amorim C.A., Luyckx V., Squifflet J. et al. A review of 15 years of ovarian tissue bank activities. J, Assist, Reprod, Genet, 2013; 30(3): 305-14. https://dx.doi.org/10.1007/s10815-013-9952-x.
67. Chan J.L., Wang E.T. Oncofertility for women with gynecologic malignancies. Gynecol. Oncol. 2017; 144(3): 631-6. https://dx.doi.org/10.1016/j.ygyno.2016.12.013.

Received 12.03.2021

Accepted 09.06.2021